Literature DB >> 15166943

Venous and arterial thrombosis in rat models: dissociation of the antithrombotic effects of glycosaminoglycans.

Patricia Zancan1, Paulo A S Mourão.   

Abstract

Fucosylated chondroitin sulfate is a glycosaminoglycan from sea cucumber, made up of alternating beta-D-glucuronic acid and N-acetyl-beta-D-galactosamine units, like mammalian chondroitin sulfate. But the beta-D-glucuronic acid residues have branches of sulfated fucose, which confer high anticoagulant and antithrombotic properties on this compound. We have now compared the anticoagulant, bleeding and antithrombotic effects of this fucosylated chondroitin sulfate and its carboxyl-reduced derivative. Both compounds have similar anticoagulant action, mostly due to acceleration of thrombin inhibition in the presence of heparin cofactor II. The native glycosaminoglycan shows a correlation among anticoagulant, bleeding and antithrombotic effects. Inhibition of thrombosis in an arterio-venous shunt occurs at low doses, which are almost ineffective in modifying the anticoagulant activity of plasma. In a venous experimental model, on the contrary, antithrombotic activity requires high doses and occurs concomitantly with an increase in the anticoagulant activity of plasma. The action of fucosylated chondroitin sulfate on thrombosis is apparently unrelated to its effect on platelet aggregation. The carboxyl-reduced derivative of fucosylated chondroitin sulfate prevented thrombosis in the arterio-venous shunt, but not in the venous experimental model. This derivative did not increase bleeding, in spite of its potent anticoagulant activity. Therefore, our results reveal a dissociation of the anticoagulant, bleeding and antithrombotic effects of the glycosaminoglycan. Furthermore, we demonstrate that a polysaccharide may be a potent inhibitor of one type of thrombotic episode, but inactive on another. We propose that the different effects of fucosylated chondroitin sulfate and its carboxyl-reduced derivative on venous thrombosis may be related to adherence of the glycosaminoglycan to the vessel wall. Copyright 2004 Lippincott Williams and Wilkins

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15166943     DOI: 10.1097/00001721-200401000-00008

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  11 in total

Review 1.  Marine pharmacology in 2003-4: marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Roberto G S Berlinck; Mark T Hamann
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2007-02-09       Impact factor: 3.228

2.  Fucosylated chondroitin sulfate inhibits Plasmodium falciparum cytoadhesion and merozoite invasion.

Authors:  Marcele F Bastos; Letusa Albrecht; Eliene O Kozlowski; Stefanie C P Lopes; Yara C Blanco; Bianca C Carlos; Catarina Castiñeiras; Cristina P Vicente; Claudio C Werneck; Gerhard Wunderlich; Marcelo U Ferreira; Claudio R F Marinho; Paulo A S Mourão; Mauro S G Pavão; Fabio T M Costa
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

3.  Sulfated Polysaccharide Isolated from the Sea Cucumber Stichopus japonicus Against PC12 Hypoxia/Reoxygenation Injury by Inhibition of the MAPK Signaling Pathway.

Authors:  Chao Cui; Ningshan Cui; Peng Wang; Shuliang Song; Hao Liang; Aiguo Ji
Journal:  Cell Mol Neurobiol       Date:  2015-05-08       Impact factor: 5.046

Review 4.  Targeting eukaryotic proteases for natural products-based drug development.

Authors:  Fatma H Al-Awadhi; Hendrik Luesch
Journal:  Nat Prod Rep       Date:  2020-06-24       Impact factor: 13.423

Review 5.  High-value components and bioactives from sea cucumbers for functional foods--a review.

Authors:  Sara Bordbar; Farooq Anwar; Nazamid Saari
Journal:  Mar Drugs       Date:  2011-10-10       Impact factor: 6.085

Review 6.  Holothurian fucosylated chondroitin sulfate.

Authors:  Vitor H Pomin
Journal:  Mar Drugs       Date:  2014-01-09       Impact factor: 5.118

Review 7.  It's all in the milk: chondroitin sulfate as potential preventative therapy for necrotizing enterocolitis.

Authors:  Thomas A Knowles; Brian D Hosfield; Anthony R Pecoraro; Hongge Li; W Christopher Shelley; Troy A Markel
Journal:  Pediatr Res       Date:  2020-09-13       Impact factor: 3.953

Review 8.  Glycosaminoglycans analogs from marine invertebrates: structure, biological effects, and potential as new therapeutics.

Authors:  Mauro S G Pavão
Journal:  Front Cell Infect Microbiol       Date:  2014-09-10       Impact factor: 5.293

9.  Marine organism sulfated polysaccharides exhibiting significant antimalarial activity and inhibition of red blood cell invasion by Plasmodium.

Authors:  Joana Marques; Eduardo Vilanova; Paulo A S Mourão; Xavier Fernàndez-Busquets
Journal:  Sci Rep       Date:  2016-04-13       Impact factor: 4.379

10.  Structural and haemostatic features of pharmaceutical heparins from different animal sources: challenges to define thresholds separating distinct drugs.

Authors:  Ana M F Tovar; Gustavo R C Santos; Nina V Capillé; Adriana A Piquet; Bianca F Glauser; Mariana S Pereira; Eduardo Vilanova; Paulo A S Mourão
Journal:  Sci Rep       Date:  2016-10-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.